OakChart

Natera Inc

NTRAHealthcare·Diagnostics & Research·USA·Large·NASD·Nov 11 • 3:59 PM ET

319.82+7.84 (2.51%)
2026-11-12 02:36 CET
Market cap
45,238.66 USD m
Revenue, TTM
2,908.87 USD m
Net income, TTM
-164.71 USD m
Free cash flow, TTM
52.47 USD m
EPS diluted, TTM
-1.15
P/E
-
Compare

Price

NTRA against its 20, 50 and 200-day averages
2050200beatmiss
200.00300.00400.002.9M5.8MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NTRAclose 319.8220-day 384.9050-day 379.91200-day 270.49319.8252w high52w low

26.9% under the 52-week high of 437.41 on 6 Oct 2026. 52-week low 181.00 on 27 Mar 2026. Last 15 sessions, 43.5% high to low

Volume 1.03× normal · the line is the 50-bar volume average

Profile

NTRA
52-week range, 54% of the way up
181437.41

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

IndexRUI
Employees6140
IPOJul 02, 2015
Beta1.55
ATR, 14d22.20
Rel volume1.03
Short float4.48%
Insider own6.42%
Inst own97.70%

Snapshot

6 groups

Valuation

IndexRUI
Market Cap46.38B
Enterprise Value45.52B
Income-164.71M
Sales2.91B
Book/sh12.95
Cash/sh7.57
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees6140
IPOJul 02, 2015

Ratios

P/E-
Forward P/E-
PEG-
P/S15.94
P/B24.69
P/C42.27
P/FCF883.84
EV/EBITDA-
EV/Sales15.65
Quick Ratio2.66
Current Ratio2.81
Debt/Eq0.13
LT Debt/Eq0.08
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.15
EPS next Y-0.47
EPS next Q-0.14
EPS this Y-3.96%
EPS next Y70.16%
EPS next 5Y-
EPS past 3/5Y35.09% 11.70%
Sales past 3/5Y41.14% 42.61%
EPS Y/Y TTM49.82%
Sales Y/Y TTM37.43%
EPS Q/Q34.82%
Sales Q/Q34.08%
EarningsNov 05 AMC
EPS/Sales Surpr.-49.47% 12.22%

Ownership

Insider Own6.42%
Insider Trans-6.67%
Inst Own97.70%
Inst Trans0.66%
ROA-7.21%
ROE-10.55%
ROIC-8.19%
Gross Margin64.50%
Oper. Margin-8.82%
Profit Margin-5.66%
SMA20-16.91%
SMA50-15.82%
SMA20018.24%
Trades-

Technical

Shs Outstand144.34M
Shs Float135.69M
Short Float4.48%
Short Ratio3.58
Short Interest6.07M
52W High437.41 -26.88%
52W Low181.00 76.70%
Volatility5.85% 5.26%
ATR (14)22.20
RSI (14)33.72
Beta1.55
Rel Volume1.03
Avg Volume1.69M
Volume1,746,890

Performance

Perf Week-18.21%
Perf Month-19.17%
Perf Quarter2.91%
Perf Half Y63.74%
Perf YTD39.60%
Perf Year54.71%
Perf 3Y584.25%
Perf 5Y182.50%
Perf 10Y2768.34%
Recom1.44
Target Price412.75
Prev Close311.98
Price319.82
Change %2.51%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 23, 2026InitiatedRRoth CapitalBuy$475+48.5%
Sep 09, 2026ResumedUUBSBuy$435+36.0%
Sep 08, 2026InitiatedRRothschild & Co RedburnBuy$385+20.4%
Jun 26, 2026ResumedBBernsteinOutperform$310-3.1%
Jun 12, 2026ResumedRRBC Capital MktsOutperform$275-14.0%
Jun 02, 2026ResumedWWolfe ResearchOutperform$260-18.7%
Apr 14, 2026InitiatedWWilliam BlairOutperform
Jan 07, 2026InitiatedCCitigroupBuy$300-6.2%
Dec 02, 2025ResumedMMorgan StanleyOverweight$265-17.1%
Oct 27, 2025UpgradeBBNP Paribas ExaneUnderperform → Neutral$172-46.2%

Peers

Mkt cap
TickerCompanyMkt cap
GHGuardant Health Inc20.94B
BLLNBilliontoone Inc5.27B
CDNACaredx Inc4.26B
LHLabcorp Holdings Inc30.23B
MYGNMyriad Genetics Inc548.68M
DGXQuest Diagnostics Inc28.46B
NEONeogenomics Inc2.18B
GRALGRAIL Inc5.65B
TEMTempus AI Inc14.49B
CAICaris Life Sciences Inc7.02B

Insider trading

latest 14 of 100
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Sheena JonathanCO-FOUNDERNov 06 '26Sale316.003,150995,405214,462Nov 10 09:05 PM
Sheena JonathanCO-FOUNDERNov 02 '26Sale399.9711244,797217,574Nov 04 09:35 PM
Rabinowitz MatthewEXECUTIVE CHAIRMANNov 02 '26Sale400.02748299,2142,116,928Nov 04 09:35 PM
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICERNov 02 '26Sale400.05341136,416167,880Nov 04 09:35 PM
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSNov 02 '26Sale409.773,4191,400,994101,323Nov 04 09:35 PM
Fesko JohnPRESIDENT, CHIEF BUS. OFFICERNov 02 '26Sale400.01302120,804195,276Nov 04 09:35 PM
Chapman Steven LeonardCEO AND PRESIDENTNov 02 '26Sale411.803,8011,565,23987,431Nov 04 09:35 PM
Brophy Michael BurkesCHIEF FINANCIAL OFFICERNov 03 '26Sale391.49470184,00045,779Nov 04 09:35 PM
Brophy Michael BurkesCHIEF FINANCIAL OFFICERNov 02 '26Sale399.99325129,99846,249Nov 04 09:35 PM
MICHAEL BROPHYOfficerNov 03 '26Proposed Sale378.92470178,092Nov 03 04:31 PM
STEVEN L CHAPMANOfficerNov 02 '26Proposed Sale415.642,8661,191,224Nov 02 04:14 PM
JONATHAN SHEENADIRECTORNov 02 '26Proposed Sale414.3010844,744Nov 02 04:06 PM
MATTHEW RABINOWITZDIRECTORNov 02 '26Proposed Sale414.30722299,125Nov 02 04:06 PM
DANIEL RABINOWITZOFFICERNov 02 '26Proposed Sale414.30330136,719Nov 02 04:05 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IBBiShares Biotechnology ETFAUM: 11.36B
IWPiShares Russell Mid-Cap Growth ETFAUM: 18.09B
IWRiShares Russell Mid-Cap ETFAUM: 58.68B
VHTVanguard Health Care ETFAUM: 21.51B
IWFiShares Russell 1000 Growth ETFAUM: 116.57B
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-05-0.420-0.281-0.420793.98707.5419
2026Q22026-08-06-0.470-0.494-0.467752.75661.2418
2026Q12026-05-07-0.600-0.542-0.601696.64617.117
2025Q42026-02-260.360-0.5120.338665.5604.0420
2025Q32025-11-06-0.640-0.386-0.638592.18513.4519
2025Q22025-08-07-0.740-0.616-0.740546.6476.2619
2025Q12025-05-08-0.500-0.641-0.497501.83446.2320
2024Q42025-02-27-0.410-0.381-0.409476.1435.6419
2024Q32024-11-12-0.260-0.575-0.255439.76361.4318
2024Q22024-08-08-0.300-0.689-0.305413.3534317
2024Q12024-05-09-0.560-0.705-0.560367.74316.3115
2023Q42024-02-28-0.650-0.770-0.654311.130016
2023Q32023-11-08-0.950-0.958-0.947268.31259.2713
2023Q22023-08-03-0.970-1.088-0.975261.4241.6714
2023Q12023-05-09-1.230-1.155-1.225241.76227.1313
2022Q42023-02-28-1.370-1.422-1.367217.3215.5713

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-1.790-1.886-1.795302.33296.92
2020FY-2.840-2.537-2.836391.01385.24
2021FY-5.210-5.019-5.209625.49621.43
2022FY-5.570-5.602-5.567820.22819.43
2023FY-3.780-3.959-3.7811,0831,070
2024FY-1.530-1.498-1.5271,6971,652
2025FY-1.520-2.397-1.5202,3062,243
2026FY--1.580--2,996
2027FY--0.472--3,645
2028FY-1.053--4,477
2029FY-2.344--5,487
2030FY-4.191--6,458

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0920140772.79743.3798
2026Q4S2026-11-0620120769.63743.3796
2026Q4S2026-11-052001749.53740.8760.89
2026Q4S2026-10-262001749.53740.8760.89
2026Q4S2026-10-252001749.53740.8760.89
2026Q4S2026-10-242002749.53740.8760.89
2026Q4S2026-10-222012749.53740.8760.89
2026Q4S2026-10-211912748.94740.8760.89
2026Q4S2026-10-131943748.94740.8760.89
2026Q4S2026-10-121943748.96740.8760.89
2026Q4S2026-10-091943748.68740.8760.89
2026Q4S2026-10-061933748.66740.8760.89
2026Q4S2026-09-301932749.19740.8760.89
2026Q4S2026-09-281932749.01740.8760.89

Estimate history

EPS, annual-2.589-2.215-1.795-2.836-5.209-5.567-3.781-1.527-1.523-1.1463
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.255-0.409-0.497-0.74-0.6380.338-0.601-0.467-0.416
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual209.625257.654302.328391.005625.486820.2221082.5711696.9112306.1132908.87
Period201720182019202020212022202320242025TTM
Sales, quarterly439.758476.061501.83546.6592.183665.498696.644752.75793.981
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual54.0462.08278.00586.22395.14111.255119.581132.646139.693144.345
Period201720182019202020212022202320242025MRQ
Shares, quarterly124.137132.646135.932136.757137.533139.693142.734143.612144.345
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue2,908.872,306.111,696.911,082.57820.22625.49391.00302.33257.65
Cost of Goods Sold Incl. D&A1,032.79814.65673.75589.83456.26318.42203.62175.47166.06
Gross Profit1,876.081,491.461,023.16492.74363.97307.07187.38126.8691.60
Selling, General and Administrative Excl. Other2,132.591,797.471,245.45936.31895.72739.64403.66255.96204.68
Research and Development856.40624.11404.14318.00307.12228.60100.0351.3649.81
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-256.51-306.01-222.29-443.57-531.75-432.57-216.28-129.10-113.08
Interest Expense3.684.0710.6912.649.328.3015.0810.6910.48
Unusual Expense3.903.900.002.689.2935.605.851.575.66
Net Income Before Taxes-224.98-268.09-189.73-434.53-546.82-471.10-229.65-122.83-127.83
Income Taxes-60.26-59.930.690.270.980.620.102.000.32
Consolidated Net Income-164.71-208.16-190.43-434.80-547.80-471.72-229.74-124.83-128.15
Net Income From Continuing Operations-164.71-208.16-190.43-434.80-547.80-471.72-229.74-124.83-128.15
Net Income-164.71-208.16-190.43-434.80-547.80-471.72-229.74-124.83-128.15
EPS (Recurring)-1.12-1.50-1.53-3.76-5.50-4.93-2.79-1.78-2.15
EPS (Basic, Before Extraordinaries)-1.15-1.52-1.53-3.78-5.57-5.21-2.84-1.79-2.22
EPS (Diluted)-1.15-1.52-1.53-3.78-5.57-5.21-2.84-1.79-2.22
EBITDA-179.04-262.53-191.33-404.95-501.28-421.32-207.66-121.37-105.58
Non-Operating Income (Expense)39.1145.8943.2524.353.545.387.5618.541.39
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense313.54279.98216.80187.35149.9482.9935.9320.4311.12
Price To Sales Ratio20.4713.5811.636.654.8213.5220.627.753.13
Gross Margin64.5064.6760.3045.5244.3749.0947.9241.9635.55
Operating Margin-8.82-13.27-13.10-40.97-64.83-69.16-55.31-42.70-43.89
Net Margin-5.66-9.03-11.22-40.16-66.79-75.42-58.76-41.29-49.74
Shares Outstanding144.34139.69132.65119.58111.2595.1486.2278.0062.08
Market Capitalization45,238.6645,238.6620,898.927,526.324,379.868,834.218,496.012,611.95863.06

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue793.98752.75696.64665.50592.18546.60501.83476.06
Cost of Goods Sold Incl. D&A286.21273.27251.52221.79207.80200.00185.06176.42
Gross Profit507.77479.48445.12443.71384.38346.60316.76299.64
Selling, General and Administrative Excl. Other576.09555.27538.64462.59481.96456.98395.94364.38
Research and Development242.43228.07210.70175.19173.41146.43129.08129.46
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-68.32-75.79-93.52-18.89-97.58-110.37-79.18-64.74
Interest Expense0.900.890.890.991.041.031.001.29
Unusual Expense0.000.000.003.900.000.000.000.00
Net Income Before Taxes-59.61-67.23-84.81-13.33-87.34-100.66-66.76-55.13
Income Taxes0.30-0.260.28-60.580.210.280.17-1.35
Consolidated Net Income-59.91-66.97-85.0947.26-87.54-100.94-66.94-53.77
Net Income From Continuing Operations-59.91-66.97-85.0947.26-87.54-100.94-66.94-53.77
Net Income-59.91-66.97-85.0947.26-87.54-100.94-66.94-53.77
EPS (Recurring)-0.42-0.47-0.600.36-0.64-0.74-0.50-0.41
EPS (Basic, Before Extraordinaries)-0.42-0.47-0.600.34-0.64-0.74-0.50-0.41
EPS (Diluted)-0.42-0.47-0.600.34-0.64-0.74-0.50-0.41
EBITDA-46.36-54.60-73.29-4.79-87.28-100.51-69.94-56.95
Non-Operating Income (Expense)9.619.459.6010.4511.2810.7413.4210.91
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense83.8281.4575.1373.1471.6073.7561.4856.82
Price To Sales Ratio20.4714.3711.3213.8810.4311.7310.4112.26
Gross Margin63.9563.7063.9066.6764.9163.4163.1262.94
Operating Margin-8.60-10.07-13.42-2.84-16.48-20.19-15.78-13.60
Net Margin-7.55-8.90-12.217.10-14.78-18.47-13.34-11.29
Shares Outstanding144.34143.61142.73139.69137.53136.76135.93132.65
Market Capitalization45,238.6638,875.7128,344.7831,687.9622,092.8123,068.2519,116.6520,898.92

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments1,076.14968.28878.98898.39914.51737.46441.05158.47118.93
Short Term Receivables296.53314.17278.29244.38122.0778.5653.3562.2244.09
Inventories68.4444.7440.7635.4126.9120.0312.3913.639.00
Other Current Assets55.8348.6360.5233.6329.6426.6116.386.208.61
Total Current Assets1,496.941,375.821,258.551,211.821,093.14862.66523.17240.52180.62
Net Property, Plant & Equipment349.73248.19167.75164.33124.5354.7547.0124.3429.67
Total Investments and Advances0.000.000.000.000.000.000.000.000.34
Intangible Assets514.78------0.000.00
Deferred Tax Assets109.6925.6715.4320.0815.8725.667.16--
Other Assets36.9036.7215.4018.3318.8214.7412.483.323.98
Total Assets2,508.041,686.401,457.121,414.551,252.36957.82589.82268.17214.61
Short Term Debt Incl. Current Port. of LT Debt95.9090.5392.0287.9955.8057.3555.8650.1550.11
Accounts Payable33.1634.9215.0031.1527.218.108.6014.598.53
Income Tax Payable8.374.423.734.32---1.250.50
Other Current Liabilities303.80214.18196.52187.04135.95133.60115.4147.9946.42
Total Current Liabilities441.23344.05307.27310.50218.96199.05179.87113.98105.56
Long Term Debt118.4796.59349.97358.23341.43223.7499.9573.3673.06
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities110.3925.6715.4320.0815.8725.667.16--
Other Liabilities125.5324.6819.1320.0022.8023.1224.1248.6710.57
Total Liabilities795.62490.98691.80708.81599.06471.58311.11236.01189.20
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,712.411,195.42765.33705.74653.30486.24278.7132.1625.42
Total Shareholders Equity1,712.411,195.42765.33705.74653.30486.24278.7132.1625.42
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity1,712.411,195.42765.33705.74653.30486.24278.7132.1625.42
Total Liabilities & Stockholders Equity2,508.041,686.401,457.121,414.551,252.36957.82589.82268.17214.61
Book Value Per Share12.269.016.406.346.875.643.570.520.47
Tangible Book Value Per Share8.579.016.406.346.875.643.570.520.47
Full-Time Employees6,1404,4343,2933,0182,6701,8151,039975893
Price to Book Ratio24.0922.379.5010.8113.6017.659.4326.9516.00
Return on Assets-9.93-12.12-30.28-41.08-42.69-29.69-29.10-57.35-64.72
Return on Equity-14.32-19.42-59.11-80.62-82.79-60.07-80.31-1,176.16-208.70
Return on Invested Capital-11.37-14.74-38.99-51.49-47.42-32.36-32.97-121.45-139.75
Quick Ratio3.243.873.963.794.874.232.841.991.63
Current Ratio3.394.004.103.904.994.332.912.111.71

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-164.71-208.16-190.43-434.80-547.80-471.72-229.74-124.83-128.15
Depreciation77.4843.4830.9738.6230.4711.258.617.737.50
Other Funds (Non Cash)429.86369.93292.98197.18170.51171.3077.7526.4522.92
Funds from Operations281.82144.46133.52-199.00-346.82-289.16-143.38-90.64-97.74
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-69.0470.842.14-47.95-84.68-46.07-39.1327.2027.16
Cash from Operating Activities212.78215.30135.66-246.96-431.50-335.24-182.51-63.44-70.58
Capital Expenditures-180.82-139.19-76.92-39.20-47.70-41.03-19.60-4.97-3.88
Net Assets From Acquisitions-16.26-16.020.000.000.00-8.560.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.009.68-
Purchase or Sale of Investments-9.0023.00214.54207.70378.04-155.60-311.86-271.06-1.28
Purchase of Investments-10.000.00-124.68-98.30-86.95-876.10-685.24-446.63-170.27
Sale Or Maturity of Investments1.0023.00339.22306.00464.98720.49373.38175.57168.99
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-206.08-132.21137.62168.50330.34-205.19-331.46-266.35-5.16
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock54.4747.4630.29254.46452.64576.19301.29340.77113.72
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock54.4747.4630.29254.46452.64576.19301.29340.77113.72
Proceedsfrom Stock Options29.0124.9317.30250.57446.23564.37277.76327.73100.39
Issuance or Reduction of Debt, Net0.000.00-0.080.0030.000.00199.560.000.00
Change in Long Term Debt0.000.00-0.080.0030.000.00199.560.000.00
Issuance of Long Term Debt0.000.000.000.0030.000.00278.320.000.00
Reduction of Long Term Debt0.000.00-0.080.000.000.00-78.760.000.00
Net Financing Active Other Cash Flow-5.410.000.000.000.000.000.000.000.00
Other Financing Activities Uses-5.410.000.000.000.000.000.000.000.00
Cash from Financing Activities49.0547.4630.20254.46482.64576.19500.85340.77113.72
Net Change in Cash55.76130.55303.49176.00381.4835.76-13.1310.9837.98
Free Cash Flow52.47109.1169.24-286.15-479.20-376.27-202.12-68.41-74.46
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow1,134.89287.05285.13------
Deferred Taxes & Investment Tax Credit--60.800.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments1,097.191,091.501,087.931,076.141,042.441,016.00
Short Term Receivables471.35421.97417.60296.53286.38309.22
Inventories91.7080.3570.7268.4464.6454.27
Other Current Assets62.3665.1375.5655.8353.8652.10
Total Current Assets1,722.611,658.951,651.811,496.941,447.321,431.60
Net Property, Plant & Equipment483.40447.25403.37349.73303.48284.35
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets494.14501.30508.22514.7830.00-
Deferred Tax Assets---109.69--
Other Assets48.2649.9951.0036.9040.6741.12
Total Assets2,748.412,657.502,614.402,508.041,821.481,757.07
Short Term Debt Incl. Current Port. of LT Debt96.2395.4195.1395.9094.3593.39
Accounts Payable120.1875.1562.4033.1646.5036.88
Income Tax Payable7.669.359.398.377.166.54
Other Current Liabilities388.83373.28391.34303.80294.01248.03
Total Current Liabilities612.90553.20558.26441.23442.02384.84
Long Term Debt142.62143.07144.95118.47104.38102.74
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.700.700.70110.39--
Other Liabilities122.64139.02136.47125.5322.9023.31
Total Liabilities878.86836.00840.38795.62569.29510.88
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,869.561,821.501,774.021,712.411,252.191,246.18
Total Shareholders Equity1,869.561,821.501,774.021,712.411,252.191,246.18
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1,869.561,821.501,774.021,712.411,252.191,246.18
Total Liabilities & Stockholders Equity2,748.412,657.502,614.402,508.041,821.481,757.07
Book Value Per Share12.9512.6812.4312.269.109.11
Tangible Book Value Per Share9.539.198.878.578.899.11
Full-Time Employees---6,140--
Price to Book Ratio24.0921.8416.3125.1617.6618.52
Return on Assets-7.21-8.71-10.41-9.93-18.12-15.47
Return on Equity-10.55-12.54-15.02-14.32-29.02-24.32
Return on Invested Capital-2.98-3.41-4.432.58-6.45-7.48
Quick Ratio2.662.852.833.243.133.58
Current Ratio2.813.002.963.393.273.72

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-59.91-66.97-85.0947.26-87.54-100.94
Depreciation21.9721.1920.2314.1010.299.86
Other Funds (Non Cash)119.95104.44107.8697.6295.7197.85
Funds from Operations82.0058.6643.0098.1718.466.77
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-38.07-3.86-2.83-24.2840.9330.80
Cash from Operating Activities43.9354.7940.1773.8959.3937.57
Capital Expenditures-38.68-63.43-22.14-56.57-34.91-25.90
Net Assets From Acquisitions-0.240.000.00-16.020.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.00-10.001.0015.002.00
Purchase of Investments0.000.00-10.000.000.000.00
Sale Or Maturity of Investments0.000.000.001.0015.002.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-38.92-63.43-32.14-71.59-19.91-23.90
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock1.0017.303.7632.411.9412.58
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock1.0017.303.7632.411.9412.58
Proceedsfrom Stock Options0.0016.43-0.1012.690.0012.24
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.32-5.100.000.000.000.00
Other Financing Activities Uses-0.32-5.100.000.000.000.00
Cash from Financing Activities0.6812.213.7632.411.9412.58
Net Change in Cash5.693.5711.7934.7041.4226.25
Free Cash Flow5.25-8.6418.0337.8236.9811.68
Price to Free Cash Flow1,134.89461.93270.78293.29208.20220.37

Revenue breakdown

Licensing and other2024: 11.84M 2025: 10.29M
Product2024: 1.69B 2025: 2.30B
Americas, excluding U.S.2024: 6.62M 2025: 9.35M
Asia Pacific and Other2024: 8.66M 2025: 8.01M
Europe, Middle East, India, and Africa2024: 23.88M 2025: 24.48M
United States2024: 1.66B 2025: 2.26B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.48%6.1M135.7M1.54M
2026-10-154.34%5.9M134.9M1.44M
2026-09-304.71%6.4M134.9M1.38M
2026-09-153.56%4.8M134.9M1.39M
2026-08-314.10%5.5M134.6M1.40M
2026-08-143.19%4.3M134.6M1.47M
2026-07-313.19%4.4M136.9M1.50M
2026-07-153.63%5.0M136.9M1.56M
2026-06-304.25%5.8M136.9M1.56M
2026-06-153.15%4.3M136.8M1.40M
2026-05-292.65%3.6M136.6M1.44M
2026-05-152.77%3.8M136.5M1.37M
2026-04-302.99%4.0M134.7M1.26M
2026-04-152.80%3.8M134.6M1.22M
2026-03-313.61%4.9M134.8M1.20M
2026-03-132.45%3.3M134.8M1.17M
2026-02-272.22%3.0M134.8M1.14M
2026-02-132.49%3.3M131.6M1.28M
2026-01-302.58%3.4M131.7M1.35M
2026-01-152.63%3.5M131.6M1.36M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call95.00223.2226.81774.4703.000.000.993-0.2100.010
call100217.9221.9216.914.2913.000.000.993-0.2100.010
call105213.3216.73234.0783.000.000.992-0.2100.011
call110208.3211.72153.9184.001.000.992-0.2100.011
call115203.3206.8298.13.8051.000.000.992-0.2100.011
call120198.2201.8193.33.6584.000.000.991-0.2100.012
call125193.1196.8143.183.5171.000.000.991-0.2100.012
call130188.2191.82353.41718.000.000.990-0.2100.013
call135183.2186.8133.33.2531.000.000.990-0.2090.013
call140178.2181.8173.73.16119.000.000.990-0.2090.014
call145173.2176.8168.63.0081.000.000.989-0.2090.014
call150168.3171.8164.92.8924.000.000.989-0.2080.015
call155163166.91652.7802.000.000.988-0.2080.015
call160158.3161.982.502.7003.000.000.988-0.2070.016
call165153.3156.9164.962.5942.000.000.987-0.2070.016
call170148.3151.8109.72.4643.000.000.987-0.2060.017
call175143.4146.8149.62.3651.001.000.986-0.2060.017
call180138.4141.843.502.2686.000.000.986-0.2050.018
call1851331371292.1992.000.000.985-0.2040.019
call190128.4131.9139.72.1063.000.000.984-0.2030.020
call195123.3126.9117.22.0167.000.000.984-0.2020.020
call200118.3121.9121.41.9282810.000.983-0.2010.021
call210108.4111.9155.951.7582130.000.981-0.1990.023
call22098.40101.995.601.6322690.000.979-0.1970.025
call23088.4092.0090.001.4552040.000.977-0.1940.027
call24078.5082.10174.921.3014730.000.975-0.1910.030
call25068.5072.10115.331.1665030.000.971-0.1870.033
call26058.7062.1053.501.0192000.000.967-0.1820.036
call27048.9052.4049.230.9106071.000.934-0.3030.064
call28039.4042.9043.200.81359.001.000.873-0.4940.103
call29030.4034.0024.300.76355.000.000.818-0.5830.132
call30022.3025.5025.000.70487.000.000.746-0.6410.159
call31015.1018.5017.400.6561331.000.643-0.7070.186
call3209.5012.5010.360.62720328.000.521-0.7180.198
call3305.008.507.800.6371087.000.397-0.6980.192
call3401.905.502.980.64120823.000.288-0.6220.170
call3500.154.002.400.6841,07514.000.216-0.5710.146
call3600.001.501.400.5921000.000.110-0.3160.093
call3700.051.800.750.6892370.000.097-0.3360.085
call3800.002.450.300.7791210.000.088-0.3530.079
call3900.002.200.820.86567.000.000.081-0.3680.075
call4000.002.150.050.9471620.000.075-0.3810.071
call4100.002.150.051.0251720.000.071-0.3920.067
call4200.002.151.151.1002556.000.067-0.4030.064
call4300.002.151.081.1722381330.063-0.4120.062
call4400.002.151.091.24110414.000.061-0.4210.060
call4500.002.151.051.3085261270.058-0.4290.058
call4600.002.150.501.2732970.000.042-0.3210.044
call4700.002.150.401.3331830.000.040-0.3260.043
call4800.000.751.500.94467.000.000.004-0.0290.005
call4900.002.153.100.9862000.000.003-0.0290.005
call5000.000.050.031.0131,5510.000.003-0.0290.005
call5100.002.150.051.06724.000.000.003-0.0300.005
call5200.002.152.701.10623.000.000.003-0.0300.005
call5300.002.152.151.1455.000.000.003-0.0300.005
call5400.002.150.901.1823.000.000.003-0.0300.005
call5500.002.151.071.2187.000.000.003-0.0300.004
call5600.002.150.551.25423.000.000.003-0.0310.004
call5700.002.150.051.2890.000.000.003-0.0310.004
call5800.002.151.001.3233.000.000.003-0.0310.004
call5900.002.150.501.3575.000.000.003-0.0310.004
call6000.002.150.601.39012.000.000.003-0.0310.004
call6100.002.150.501.4228.000.000.003-0.0310.004
put95.000.002.150.003.5960.000.00-0.007-0.2000.010
put1000.002.151.353.4512.000.00-0.007-0.1990.010
put1050.002.150.003.3140.000.00-0.008-0.1990.011
put1100.002.150.763.18429.000.00-0.008-0.1980.011
put1150.002.151.803.0592.000.00-0.008-0.1980.011
put1200.002.150.102.9402.000.00-0.009-0.1970.012
put1250.002.151.002.8266.000.00-0.009-0.1960.012
put1300.002.150.102.7161.000.00-0.010-0.1950.013
put1350.002.150.002.6110.000.00-0.010-0.1940.013
put1400.002.155.152.51053.000.00-0.010-0.1940.014
put1450.002.1511.002.4713.000.00-0.018-0.2850.023
put1500.002.150.052.37399.000.00-0.019-0.2830.023
put1550.002.151.052.22613.000.00-0.012-0.1910.015
put1600.002.158.682.13712.000.00-0.012-0.1900.016
put1650.002.151.072.05135.000.00-0.013-0.1890.016
put1700.002.150.841.9686850.00-0.013-0.1870.017
put1750.002.150.201.88722.000.00-0.014-0.1860.017
put1800.002.150.401.8081,2720.00-0.014-0.1850.018
put1850.002.150.101.7316150.00-0.015-0.1840.019
put1900.002.150.801.6564660.00-0.016-0.1820.020
put1950.002.151.061.58317.000.00-0.016-0.1810.020
put2000.002.150.051.6251,0600.00-0.028-0.2840.032
put2100.002.150.181.4882,0140.00-0.030-0.2790.034
put2200.002.150.381.2392790.00-0.021-0.1720.025
put2300.002.1518.801.1115.000.00-0.023-0.1680.027
put2400.002.150.600.98750.000.00-0.025-0.1640.030
put2500.002.200.890.86732.000.00-0.029-0.1590.033
put2600.000.501.000.75010.000.00-0.033-0.1530.036
put2700.151.151.030.75857.000.00-0.066-0.2730.064
put2800.002.651.450.79837.000.00-0.127-0.4620.103
put2900.153.901.850.7482325.00-0.182-0.5500.132
put3001.805.503.800.68734412.00-0.254-0.6080.159
put3104.608.306.330.6521476.00-0.357-0.6720.186
put3208.8012.3011.700.62396566.00-0.479-0.6830.198
put33014.6017.9020.820.6182420.00-0.603-0.6610.192
put34021.8024.9022.790.6204552.00-0.712-0.5840.170
put35030.0033.5029.420.661819400-0.784-0.5330.146
put36039.1042.5040.840.7028306.00-0.890-0.2760.093
put37048.7052.3062.480.80948.000.00-0.903-0.2950.086
put38058.5062.0061.400.8597481.00-0.912-0.3110.079
put39068.4071.8079.900.93984.000.00-0.919-0.3250.075
put40078.3081.9080.081.0264941.00-0.925-0.3360.071
put41088.3091.8099.801.11023.000.00-0.929-0.3470.067
put42098.30101.899.521.18910.000.00-0.933-0.3560.064
put430108.3111.81111.26616.000.00-0.937-0.3650.062
put440118.3121.8119.491.3404.000.00-0.939-0.3720.060
put450128.3131.8135.221.4110.000.00-0.942-0.3790.058
put460138.3141.868.961.4801.000.00-0.958-0.2700.044
put470148.2151.8159.41.5620.000.00-0.960-0.2740.043
put480158.3161.8165.21.5970.000.00-0.9960.0240.005
put490168.3171.8165.11.6750.001.00-0.9970.0250.005
put500178.3181.8177.41.7670.001.00-0.9970.0260.005
put510188.3191.8185.11.7800.001.00-0.9970.0270.005
put520198.3201.8111.21.9020.000.00-0.9970.0280.005
put530208.2211.8138.71.9270.000.00-0.9970.0290.005
put540218.3221.8228.61.9661.000.00-0.9970.0300.005
put550228.3231.8225.12.0200.001.00-0.9970.0310.004
put560238.3241.80.002.0550.000.00-0.9970.0320.004
put570248.2251.80.002.1410.000.00-0.9970.0330.004
put580258.2262.11822.1920.000.00-0.9970.0340.004
put590268.3271.8219.32.2050.000.00-0.9970.0340.004
put600278.2282.10.002.2900.000.00-0.9970.0350.004
put610288.2291.8187.52.3370.000.00-0.9970.0360.004

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-06SCHEDULE 13G/ASEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-11-05SCHEDULE 13GSEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-03144Filing for proposed sale of securities under Rule 144.SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-10-30144Filing for proposed sale of securities under Rule 144.SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-28SEC
2026-10-294Statement of changes in beneficial ownership of securities2026-10-27SEC
2026-10-294Statement of changes in beneficial ownership of securities2026-10-27SEC
2026-10-294Statement of changes in beneficial ownership of securities2026-10-27SEC
2026-10-294Statement of changes in beneficial ownership of securities2026-10-27SEC
2026-10-294Statement of changes in beneficial ownership of securities2026-10-27SEC
2026-10-294Statement of changes in beneficial ownership of securities2026-10-27SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11004.88M9
2026-100031.59M20
2026-090067.88M10
2026-08009.91M12
2026-070011.79M20
2026-060064.99M11
2026-05004.42M13
2026-04006.68M11
2026-030044.89M16
2026-020024.66M8
2026-010053.78M28
2025-120015.95M7
2025-110066.16M13

Institutional holders

Manager% owned
FMR LLC9.49%
JPMORGAN CHASE & CO8.98%
BlackRock, Inc.7.62%
PRICE T ROWE ASSOCIATES INC /MD/6.30%
VANGUARD CAPITAL MANAGEMENT LLC4.35%
VANGUARD PORTFOLIO MANAGEMENT LLC4.04%
WELLINGTON MANAGEMENT GROUP LLP2.82%
STATE STREET CORP2.55%
Duquesne Family Office LLC2.22%
FRANKLIN RESOURCES INC1.90%

Funds

Fund% owned
JPMorgan Large Cap Growth Fund3.88%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.02%
VANGUARD SMALL-CAP INDEX FUND2.18%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.26%
VANGUARD EXTENDED MARKET INDEX FUND1.15%
Fidelity Contrafund1.13%
Franklin Dynatech Fund1.01%
MFS Mid Cap Growth Fund0.93%
Growth Fund of America0.69%
iShares Biotechnology ETF0.68%

OakChart. NTRA. Cached 15 minutes.